Generic Pharmaceuticals Portfolio
Various (e.g., Tobramycin Inhalation Solution)
Key Facts
About The Ritedose Corporation
The Ritedose Corporation, founded in 1995 and headquartered in Columbia, South Carolina, has established itself as the largest CDMO specializing in sterile Blow-Fill-Seal (BFS) technology in the United States. The company operates a dual business model, providing high-speed, scalable contract manufacturing services to partners while also producing and distributing a portfolio of generic pharmaceuticals, notably claiming the largest nebulized drug portfolio in the U.S. With a production capacity of over 1.8 billion doses annually from a 100,000+ square-foot facility, Ritedose is a critical player in ensuring a stable supply of essential, sterile unit-dose medications and addressing drug shortages.
View full company profile